BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37496243)

  • 1. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
    Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
    Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
    Ben-Eltriki M; Green CJ; Maclure M; Musini V; Bassett KL; Wright JM
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00651. PubMed ID: 32996701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
    Rababa M; Rababa'h A
    BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
    Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
    BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS.
    Chinzon D; Domingues G; Tosetto N; Perrotti M
    Arq Gastroenterol; 2022; 59(2):219-225. PubMed ID: 35830032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
    Boghossian TA; Rashid FJ; Thompson W; Welch V; Moayyedi P; Rojas-Fernandez C; Pottie K; Farrell B
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011969. PubMed ID: 28301676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
    Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
    Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.
    Koyyada A
    Therapie; 2021; 76(1):13-21. PubMed ID: 32718584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
    de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
    Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What is the REAL long-term risk of proton pump inhibitors?].
    Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
    Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.
    Abramowitz J; Thakkar P; Isa A; Truong A; Park C; Rosenfeld RM
    Otolaryngol Head Neck Surg; 2016 Oct; 155(4):547-54. PubMed ID: 27188706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
    Varma S; Trudeau SJ; Li J; Freedberg DE
    Inflamm Bowel Dis; 2024 Jan; 30(1):38-44. PubMed ID: 36917215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
    Thurber KM; Otto AO; Stricker SL
    Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence.
    Maes ML; Fixen DR; Linnebur SA
    Ther Adv Drug Saf; 2017 Sep; 8(9):273-297. PubMed ID: 28861211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice.
    Bundeff AW; Zaiken K
    J Manag Care Pharm; 2013 May; 19(4):325-33. PubMed ID: 23627578
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.